ClinicalTrials.gov
ClinicalTrials.gov Menu

Disclosure of Smoking in Adolescents With Asthma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03047902
Recruitment Status : Unknown
Verified October 2016 by Imperial College London.
Recruitment status was:  Recruiting
First Posted : February 9, 2017
Last Update Posted : February 9, 2017
Sponsor:
Collaborator:
The Whittington Hospital NHS Trust
Information provided by (Responsible Party):
Imperial College London

Brief Summary:
This is an exploratory randomised matched cohort pilot study. It is hypothesised that adolescents (aged 13-16 years) with asthma attending a secondary care outpatient asthma clinic, will disclose their smoking status to a doctor or nurse, if questioned alone without a parent present and if advised that they will have biological validation of their smoking status using a carbon monoxide monitor. It is a study of 30 subjects, who will be recruited over a period of 6 months.

Condition or disease Intervention/treatment Phase
Asthma Other: Group 1 - Parents will be present for the Questionnaire. Other: Group 2- Parents will not be present for the Questionnaire Not Applicable

Detailed Description:

Background:

There are currently no recommendations for how to obtain accurate information on tobacco use from teenagers aged 13-16 years, who have asthma and are attending a secondary care outpatient clinic. The approach adopted in this study, using a simple questionnaire and Carbon Monoxide monitor to verify smoking status, could potentially allow health care professionals to identify at risk adolescents before they become regular smokers. It is proposed that adolescents will disclose more accurate information about their smoking status if questioned alone without a parent present and if advised that they will have biological validation of their smoking status, using a carbon monoxide monitor.

The objectives of the study are:

  1. Use a smoking questionnaire, which will be designed with patient and parent feedback and contribution, to measure smoking status in adolescents, attending a secondary care outpatient clinic.
  2. To assess the appropriateness and acceptability of Carbon Monoxide(CO) monitoring to correlate smoking status in adolescents attending a paediatric outpatient clinic.

Design and Methodology:

All patients will be selected from the paediatric asthma clinic list at Whittington Health. The researcher will approach them with information regarding the research using a Participant Information Sheet. The CO test and the interpretation of the results of the CO test will be explained also. The researcher will consent both the parents and adolescents in both groups for the study and CO test. The adolescent will need to give written informed consent. The adolescents in group 1 (parents present) will be aware that their parents will be able to share the information on the questionnaire, but they will assured of the confidentiality of the CO test. This will also be explained to the parent. The adolescents in group 2 (i.e. parents present) will be assured of the confidentiality of the questionnaire and CO test. The confidentiality of the results will also, be explained to the parent. The parents will consent for their child to take part in the study but the teenagers will also be asked to assent to the study. It would be made clear to the parent that the teenager has a choice to participate and their refusal is not necessarily related to the fact that they may smoke. Irrespective of whether they participate or not all parents and teenagers will have smoking advice discussed with them.

Each consenting participant will be given a short questionnaire to complete. This will include 5-6 questions about their smoking history and how much they smoke and if they have ever tried to give up and how. The questionnaire will also request some basic demographic data and postcode to help identify the potential effects of environmental pollution and passive smoking may have on the results. The questionnaire should take no longer than 5 minutes to complete.


Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 30 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Prevention
Official Title: Disclosure of Smoking in Adolescents With Asthma
Study Start Date : November 2016
Estimated Primary Completion Date : April 2017
Estimated Study Completion Date : April 2017

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Asthma Smoking

Arm Intervention/treatment
Active Comparator: Parent Present

The adolescents in group 1 (Parent Present) will be aware that their parents will be able to share the information on the questionnaire, but they will be assured of the confidentiality of the CO test. This will also be explained to the parent.

Intervention: Parents will be present for the questionnaire but not for the CO test.

Other: Group 1 - Parents will be present for the Questionnaire.

In Group 1 the parents will be present for the questionnaire. The information on the questionnaire will be disclosed to them.

In Group 2 the parents will not be present for the questionnaire and the information will not be disclosed to them.


Active Comparator: Parent Absent

The adolescents in group 2 (parents not present) will be assured of the confidentiality of the questionnaire and CO test. The confidentiality of the test will also be explained to the parent.

Intervention: Parents will not be present for the questionnaire or the CO test

Other: Group 2- Parents will not be present for the Questionnaire



Primary Outcome Measures :
  1. Ascertaining smoking status in adolescents with asthma. [ Time Frame: 6 months ]
    To ascertain if adolescents with asthma are more likely to be truthful about smoking status if questioned alone without their parents and with knowledge that this will be verified by carbon monoxide monitoring. This may provide scope for a personal intervention approach to facilitate discussion about smoking cessation intervention strategies and also may be able to be extrapolated to all paediatric outpatient units and GP surgeries.


Secondary Outcome Measures :
  1. Evidence base for protocol/guidance [ Time Frame: 1 year ]
    To provide an evidence base for producing a guidance/protocol for how best to obtain a smoking history from adolescents in a collaborative and facilitative way.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   13 Years to 16 Years   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Participants will be 13-16 years of age at the time of the study.
  • Participants will be regular patients of the asthma clinic and will have a diagnosis of asthma
  • All patients will have a consultant verification of their asthma diagnosis
  • Patients with multisystem atopy will be included in the study
  • Only patients accompanied by parents and with parental consent will be enrolled to the study.

Exclusion Criteria:

  • Patients <13 years
  • Patients attending clinic without a parent.
  • Patients with special educational needs or communication difficulties
  • Patients who don't speak English as a first language, if an interpreter is not

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03047902


Contacts
Contact: Colette Datt, BSC 07827 662081 colette.datt@nhs.net
Contact: Myra Stern, PHD 0207 288 5353 myra.stern@nhs.net

Locations
United Kingdom
Whittington Health Recruiting
London, United Kingdom, AL1 5DA
Contact: Colette Datt, BSc    07960 205 270    colette.datt@nhs.net   
Contact: Amir Hakim, PHd FHEA    07886361355    a.hakim08@imperial.ac.uk   
Sub-Investigator: Colette Datt, BSc         
Sponsors and Collaborators
Imperial College London
The Whittington Hospital NHS Trust
Investigators
Principal Investigator: Amir Hakim, PHD Imperial College London

Responsible Party: Imperial College London
ClinicalTrials.gov Identifier: NCT03047902     History of Changes
Other Study ID Numbers: 202314
First Posted: February 9, 2017    Key Record Dates
Last Update Posted: February 9, 2017
Last Verified: October 2016
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Keywords provided by Imperial College London:
Adolescent Smoking Cessation Asthma Carbon Monoxide.

Additional relevant MeSH terms:
Asthma
Bronchial Diseases
Respiratory Tract Diseases
Lung Diseases, Obstructive
Lung Diseases
Respiratory Hypersensitivity
Hypersensitivity, Immediate
Hypersensitivity
Immune System Diseases